Tucatinib vs Placebo Added to Trastuzumab and Capecitabine for Patients with Pretreated HER2+ Metastatic Breast Cancer with and without Brain Metastases (HER2CLIMB): Final Overall Survival Analysis.
暂无分享，去创建一个
S. Loi | G. Hortobagyi | L. Carey | S. Loibl | V. Borges | E. Winer | M. Pegram | S. Hurvitz | D. Slamon | I. Krop | L. Carey | K. Gelmon | D. Cameron | G. Curigliano | A. Okines | E. Paplomata | V. Mueller | W. Feng | R. Murthy | E. Hamilton | J. Ramos